REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dr.Max 28 S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Other Publishers | Other Nondepository Credit Intermediation | Lessors of Other Real Estate Property | Accounting, Tax Preparation, Bookkeeping, and Payroll Services
Full name: Dr.Max 28 S.R.O. Profile Updated: July 20, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dr.Max 28 S.R.O. is based in Slovakia. The head office is in Kosice. It operates in the Pharmacies and Drug Stores industry. It was first established on February 22, 2011. 5 - 9 (2025) employees currently work for Dr.Max 28 S.R.O.. In its most recent financial highlights, the company reported a net sales revenue drop of 11.83% in 2024. Over the same period, its total assets grew by 9.92%. The net profit margin of Dr.Max 28 S.R.O. increased by 0.36% in 2024.

Headquarters
Moldavska cesta, 8/A
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the Dr.Max 28 S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Dr.Max 28 S.R.O. report to view the information.
Registered Capital:
Purchase the Dr.Max 28 S.R.O. report to view the information.
Financial Auditors:
Purchase the Dr.Max 28 S.R.O. report to view the information.
Incorporation Date:
February 22, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dr.Max 28 S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-11.83%▼
Total operating revenue
-11.92%▼
Operating profit (EBIT)
20.46%▲
EBITDA
42.66%▲
Net Profit (Loss) for the Period
7.82%▲
Total assets
9.92%▲
Total equity
16.08%▲
Operating Profit Margin (ROS)
0.62%▲
Net Profit Margin
0.36%▲
Return on Equity (ROE)
-1.06%▼
Debt to Equity Ratio
0.16%▲
Quick Ratio
-0.2%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo